Leuprolide Recruiting Phase 2 Trials for Castration-Resistant Prostate Cancer (CRPC) / Prostate Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02543255Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)
NCT03809000A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
NCT04249154Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer
NCT02770391ARN-509 and Leuprolide in Intermediate and High-risk Prostate Cancer
NCT03899077Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP